Efficacy and safety of imipenem/cilastatin/relebactam (IMI/CS/REL): a meta-analysis of randomized controlled clinical trials
Crossref DOI link: https://doi.org/10.1186/s12879-025-11499-w
Published Online: 2025-09-26
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lei, Wenjuan
Duan, Yan
Xin, Mingyan
Tian, Min
Xu, Jia
Text and Data Mining valid from 2025-09-26
Version of Record valid from 2025-09-26
Article History
Received: 27 May 2025
Accepted: 7 August 2025
First Online: 26 September 2025
Declarations
:
: Not applicable.
: The authors declare no competing interests.